#Pharmaceutical Development

Articles (11)

• 🇺🇸 Morgan Stanley downgrades Aardvark Therapeutics stock rating on trial pause — 02/03/2026 [USA] Related: #Biotech Clinical Trials, #Stock Market Reactions
• 🇺🇸 Citizens cuts Mirum Pharmaceuticals stock price target on valuation — 26/02/2026 [USA] Related: #Financial Markets, #Healthcare Investment
• 🇺🇸 Arvinas chief accounting officer Loomis sells $13k in stock — 26/02/2026 [USA] Related: #Insider Trading, #Financial Performance
• 🇺🇸 H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty — 25/02/2026 [USA] Related: #Biotechnology, #Clinical Trials, #Stock Market Analysis
• 🇺🇸 FDA accepts Opus Genetics’ presbyopia treatment application — 25/02/2026 [USA] Related: #Ophthalmology, #Regulatory Approval
• 🇺🇸 Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule — 25/02/2026 [USA] Related: #Biotechnology, #Clinical Trials
• 🇺🇸 Citizens initiates Sionna Therapeutics stock at outperform, $63 target — 24/02/2026 [USA] Related: #Biotechnology, #Stock Market Analysis
• 🇺🇸 PTC Therapeutics exec. VP Boulding sells $408,612 in stock — 20/02/2026 [USA] Related: #Insider Trading, #Regulatory Compliance, #Analyst Coverage
• 🇺🇸 Exelixis director Smith sells $4.68m in stock after option exercise — 20/02/2026 [USA] Related: #Insider Trading, #Stock Market Performance
• 🇺🇸 Protagonist Therapeutics director Williams sells $1.48 million in shares — 18/02/2026 [USA] Related: #Biotechnology, #Executive Trading
• 🇺🇸 Telix submits European marketing application for brain cancer imaging agent — 17/02/2026 [USA] Related: #Regulatory Approval, #Oncology Technology, #Market Expansion